| Literature DB >> 8991384 |
M Röcken1, M Racke, E M Shevach.
Abstract
Organ-specific autoimmune diseases are mediated by interferon gamma (IFN-gamma)-producing T helper 1 (Th1) cells. Here, Martin Röcken and colleagues review the experimental basis for an antigen-specific therapeutic approach to inflammatory autoimmune diseases. This strategy involves selective deviation of harmful Th1 responses towards an anti-inflammatory, interleukin 4 (IL-4)-producing Th2 phenotype.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8991384 DOI: 10.1016/0167-5699(96)80556-1
Source DB: PubMed Journal: Immunol Today ISSN: 0167-5699